Should You Buy Eli Lilly Stock Now or Wait for More of a Pullback?

It's been a tough start for Eli Lilly (NYSE: LLY) stock this year. Entering this week, the pharmaceutical giant's value has fallen by 8%. While its five-year gains are still impressive at around 380%, there's been less excitement around the healthcare company and other GLP-1 stocks this year, as the healthcare sector as a whole is coming under pressure to reduce prices.But although Eli Lilly's stock has been falling, it's still not all that cheap, as it trades at 43 times its trailing earnings. That's far higher than the S&P 500 average earnings multiple of 25. For investors, the big question is whether Eli Lilly is worth such a significant premium and if it's still a good buy right now, or if you may be better off waiting for more of a decline.Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool